Avallone, A., Piccirillo, M. C., Aloj, L., Nasti, G., Delrio, P., Izzo, F., . . . Romano, C. (2015). A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme). BMC Cancer, 15(1), 69-70.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Avallone, Antonio, et al. "A Randomized Phase 3 Study on the Optimization of the Combination of Bevacizumab with FOLFOX/OXXEL in the Treatment of Patients with Metastatic Colorectal Cancer-OBELICS (Optimization of BEvacizumab ScheduLIng Within Chemotherapy Scheme)."
BMC Cancer 15, no. 1 (2015): 69-70.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Avallone, Antonio, et al. "A Randomized Phase 3 Study on the Optimization of the Combination of Bevacizumab with FOLFOX/OXXEL in the Treatment of Patients with Metastatic Colorectal Cancer-OBELICS (Optimization of BEvacizumab ScheduLIng Within Chemotherapy Scheme)."
BMC Cancer, vol. 15, no. 1, 2015, pp. 69-70.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.